McKesson Unit Prices $2.25 Billion Leveraged Loan Ahead of IPO
AI Summary
McKesson Corp.'s medical-surgical unit has successfully priced a $2.25 billion leveraged loan, setting the stage for its upcoming initial public offering. This move is significant as it not only provides the necessary capital for the unit's growth but also underscores the confidence of investors and lenders in McKesson's future prospects. Leveraging such a substantial loan ahead of an IPO indicates strategic financial planning to ensure a smooth transition to public markets.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.